Skip to content

ADAR1 Capital Management, LLC

Follow

13F filer, CIK 1940272, AUSTIN, TX

ADAR1 Capital Management, LLC reported $2,348,783,963 across 272 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 39.01% of the portfolio.

Accepted , ingested 13F-HR 0001940272-26-000033

Period
2026-09-30
Reported value
$2.35B
Holdings
272
Top 10 weight
39.01%
New
45
Sold out
50

Part of the filer group ADAR1 Capital Management, LLC

How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

Largest buys vs the previous quarter

SecurityShares changeApprox. value
XENEadded+995,479$37M
SPYadded+48,537$37M
AURAadded+5,255,727$33M
FRNMnew+1,645,800$25.9M
ABVXadded+246,119$24.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CRNXexited-1,222,080-$45.7M
INSPreduced-304,588-$21.1M
TEVAexited-277,848-$9.41M
FTHexited-361,010-$9.03M
FRNMexited-674,695-$7.34M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001940272-26-000033, largest first. % of portfolio is the value over $2,332,074,063, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,513,393 shares; 2025Q1: 2,210,019 shares; 2025Q2: 3,071,340 shares; 2025Q3: 1,350,826 shares; 2025Q4: 1,317,329 shares; 2026Q1: 1,394,019 shares; 2026Q2: 1,804,703 shares; 2026Q3: 2,050,822 shares 2,050,822$203M8.71%+246,119Timeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,684 shares; 2025Q3: 54,684 shares; 2025Q4: 54,684 shares; 2026Q1: 75,940 shares; 2026Q2: 129,087 shares; 2026Q3: 177,624 shares 177,624$135M5.81%+48,537Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,020,333 shares; 2025Q1: 939,669 shares; 2025Q2: 948,069 shares; 2025Q3: 989,182 shares; 2025Q4: 1,049,168 shares; 2026Q1: 994,119 shares; 2026Q2: 960,863 shares; 2026Q3: 951,403 shares 951,403$134M5.75%-9,460Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,508,694 shares; 2025Q1: 3,483,404 shares; 2025Q2: 1,940,797 shares; 2025Q3: 3,347,501 shares; 2025Q4: 3,428,962 shares; 2026Q1: 3,285,906 shares; 2026Q2: 3,157,008 shares; 2026Q3: 3,079,526 shares 3,079,526$113M4.83%-77,482Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,045,837 shares; 2025Q1: 940,858 shares; 2025Q2: 850,437 shares; 2025Q3: 868,780 shares; 2025Q4: 1,246,520 shares; 2026Q1: 1,425,367 shares; 2026Q2: 3,369,034 shares; 2026Q3: 3,381,364 shares 3,381,364$89.1M3.82%+12,330Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 787,478 shares; 2025Q1: 968,866 shares; 2025Q2: 535,066 shares; 2025Q3: 2,241,753 shares; 2025Q4: 2,480,968 shares; 2026Q1: 2,679,010 shares; 2026Q2: 2,330,716 shares; 2026Q3: 2,115,502 shares 2,115,502$71.5M3.06%-215,214Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,547 shares; 2025Q1: 127,548 shares; 2025Q2: 259,503 shares; 2025Q3: 189,098 shares; 2025Q4: 203,969 shares; 2026Q1: 228,899 shares; 2026Q2: 166,550 shares; 2026Q3: 1,162,029 shares 1,162,029$43.2M1.85%+995,479Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 44,826 shares; 2025Q1: 13,873 shares; 2025Q2: 35,716 shares; 2025Q3: 51,516 shares; 2025Q4: 52,116 shares; 2026Q1: 1,871,455 shares; 2026Q2: 1,029,080 shares; 2026Q3: 2,072,050 shares 2,072,050$42.8M1.84%+1,042,970Timeline
BOXXEA SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 325,450 shares; 2025Q1: 337,125 shares; 2025Q2: 337,125 shares; 2025Q3: 337,125 shares; 2025Q4: 337,125 shares; 2026Q1: 337,125 shares; 2026Q2: 337,125 shares; 2026Q3: 337,125 shares 337,125$39.9M1.71%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 720,848 shares; 2025Q2: 847,227 shares; 2025Q3: 1,176,491 shares; 2025Q4: 1,157,611 shares; 2026Q1: 1,089,818 shares; 2026Q2: 940,747 shares; 2026Q3: 974,396 shares 974,396$38.1M1.63%+33,649Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 27,900 shares; 2025Q2: 35,900 shares; 2025Q3: 37,000 shares; 2025Q4: 188,000 shares; 2026Q1: 140,672 shares; 2026Q2: 1,288,053 shares; 2026Q3: 1,139,464 shares 1,139,464$37.9M1.62%-148,589Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 130,152 shares; 2026Q3: 5,385,879 shares 5,385,879$33.8M1.45%+5,255,727Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,300 shares; 2025Q1: 59,413 shares; 2025Q2: 67,813 shares; 2025Q3: 175,919 shares; 2025Q4: 26,494 shares; 2026Q1: 227,717 shares; 2026Q2: 574,038 shares; 2026Q3: 1,034,749 shares 1,034,749$33.7M1.45%+460,711Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 414,209 shares; 2025Q1: 390,729 shares; 2025Q2: 582,147 shares; 2025Q3: 518,921 shares; 2025Q4: 540,166 shares; 2026Q1: 632,556 shares; 2026Q2: 457,907 shares; 2026Q3: 461,407 shares 461,407$30.4M1.3%+3,500Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 21,974 shares; 2025Q1: 6,074 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,392 shares; 2026Q2: 228,520 shares; 2026Q3: 229,531 shares 229,531$26.2M1.12%+1,011Timeline
FRNMFREENOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,645,800 shares 1,645,800$25.9M1.11%newTimeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 14,600 shares; 2025Q2: 57,466 shares; 2025Q3: 109,442 shares; 2025Q4: 646,767 shares; 2026Q1: 427,816 shares; 2026Q2: 619,542 shares; 2026Q3: 799,304 shares 799,304$25.9M1.11%+179,762Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,052,968 shares; 2025Q1: 1,678,063 shares; 2025Q2: 531,515 shares; 2025Q3: 197,615 shares; 2025Q4: 1,238,777 shares; 2026Q1: 3,789,132 shares; 2026Q2: 3,145,096 shares; 2026Q3: 3,237,321 shares 3,237,321$25.2M1.08%+92,225Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 678,857 shares; 2025Q1: 339,635 shares; 2025Q2: 259,659 shares; 2025Q3: 273,414 shares; 2025Q4: 213,414 shares; 2026Q1: 94,292 shares; 2026Q2: 176,689 shares; 2026Q3: 379,261 shares 379,261$25M1.07%+202,572Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,500 shares; 2026Q1: 1,500 shares; 2026Q2: 74,253 shares; 2026Q3: 84,751 shares 84,751$24.7M1.06%+10,498Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 196,248 shares; 2025Q1: 490,532 shares; 2025Q2: 53,349 shares; 2025Q3: 341,612 shares; 2025Q4: 1,253,749 shares; 2026Q1: 130,560 shares; 2026Q2: 1,565,029 shares; 2026Q3: 6,648,027 shares 6,648,027$24.6M1.05%+5,082,998Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 64,067 shares; 2025Q1: 250,000 shares; 2025Q2: 250,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,744,714 shares; 2026Q2: 2,456,677 shares; 2026Q3: 2,158,839 shares 2,158,839$24.1M1.03%-297,838Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,012,866 shares; 2026Q2: 528,295 shares; 2026Q3: 2,010,831 shares 2,010,831$23.6M1.01%+1,482,536Timeline
ENTAENANTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 41,357 shares; 2026Q1: 51,357 shares; 2026Q2: 1,344,510 shares; 2026Q3: 1,733,320 shares 1,733,320$22.8M0.98%+388,810Timeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 8,889,000 shares; 2026Q3: 8,889,000 shares 8,889,000$22.8M0.98%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 15,033 shares; 2025Q2: 34,051 shares; 2025Q3: 34,051 shares; 2025Q4: 34,051 shares; 2026Q1: 338,323 shares; 2026Q2: 283,982 shares; 2026Q3: 237,567 shares 237,567$21.2M0.91%-46,415Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 329,540 shares; 2026Q2: 387,718 shares; 2026Q3: 442,682 shares 442,682$20.3M0.87%+54,964Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 11,000 shares; 2025Q1: 21,200 shares; 2025Q2: 31,200 shares; 2025Q3: 31,200 shares; 2025Q4: 72,070 shares; 2026Q1: 56,070 shares; 2026Q2: 313,236 shares; 2026Q3: 813,236 shares 813,236$19.3M0.83%+500,000Timeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 99,600 shares; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 74,212 shares; 2025Q4: 63,474 shares; 2026Q1: 316,939 shares; 2026Q2: 57,100 shares; 2026Q3: 464,600 shares 464,600$19.2M0.82%+407,500Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 170,000 shares; 2025Q1: 177,136 shares; 2025Q2: 134,136 shares; 2025Q3: 139,136 shares; 2025Q4: 145,079 shares; 2026Q1: 133,893 shares; 2026Q2: 87,509 shares; 2026Q3: 87,509 shares 87,509$18M0.77%0Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 40,002 shares; 2025Q1: 122,921 shares; 2025Q2: 210,313 shares; 2025Q3: 349,807 shares; 2025Q4: 28,866 shares; 2026Q1: 262,058 shares; 2026Q2: 730,649 shares; 2026Q3: 952,063 shares 952,063$17.3M0.74%+221,414Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 26,045 shares; 2025Q4: 179,532 shares; 2026Q1: 50,095 shares; 2026Q2: 339,276 shares; 2026Q3: 637,353 shares 637,353$17.3M0.74%+298,077Timeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 117,909 shares; 2026Q2: 1,017,805 shares; 2026Q3: 997,356 shares 997,356$16M0.68%-20,449Timeline
RLYBRALLYBIO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,535 shares; 2026Q2: 926,352 shares; 2026Q3: 926,352 shares 926,352$15.9M0.68%0Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,796 shares; 2025Q3: 72,007 shares; 2025Q4: 72,031 shares; 2026Q1: 161,252 shares; 2026Q2: 244,184 shares; 2026Q3: 258,182 shares 258,182$15.6M0.67%+13,998Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 35,000 shares; 2025Q4: 125,375 shares; 2026Q1: 395,459 shares; 2026Q2: 252,395 shares; 2026Q3: 369,785 shares 369,785$15M0.64%+117,390Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 177,707 shares; 2025Q1: 1,066,309 shares; 2025Q2: 3,009,870 shares; 2025Q3: 2,835,680 shares; 2025Q4: 2,495,809 shares; 2026Q1: 2,979,429 shares; 2026Q2: 3,040,466 shares; 2026Q3: 3,059,567 shares 3,059,567$14.9M0.64%+19,101Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 130,037 shares; 2025Q1: 100,774 shares; 2025Q2: 100,974 shares; 2025Q3: 129,999 shares; 2025Q4: 233,908 shares; 2026Q1: 264,278 shares; 2026Q2: 217,595 shares; 2026Q3: 179,032 shares 179,032$14.3M0.61%-38,563Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 31,509 shares; 2025Q1: 153,767 shares; 2025Q2: 62,088 shares; 2025Q3: 351,032 shares; 2025Q4: 245,452 shares; 2026Q1: 298,546 shares; 2026Q2: 420,881 shares; 2026Q3: 823,876 shares 823,876$14.2M0.61%+402,995Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,941 shares; 2025Q1: 36,890 shares; 2025Q2: 45,390 shares; 2025Q3: 49,571 shares; 2025Q4: 51,349 shares; 2026Q1: 211,450 shares; 2026Q2: 136,158 shares; 2026Q3: 138,658 shares 138,658$13.2M0.57%+2,500Timeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,375,009 shares; 2025Q3: 1,469,098 shares; 2025Q4: 1,457,764 shares; 2026Q1: 1,581,443 shares; 2026Q2: 1,554,535 shares; 2026Q3: 1,522,103 shares 1,522,103$12.8M0.55%-32,432Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 12,200 shares; 2026Q3: 392,422 shares 392,422$12.6M0.54%+380,222Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,361 shares; 2025Q1: 1,361 shares; 2025Q2: 3,361 shares; 2025Q3: 15,700 shares; 2025Q4: 12,051 shares; 2026Q1: 12,154 shares; 2026Q2: 22,208 shares; 2026Q3: 16,446 shares 16,446$12.5M0.53%-5,762Timeline
BILSPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 131,786 shares; 2025Q1: 135,585 shares; 2025Q2: 135,585 shares; 2025Q3: 135,585 shares; 2025Q4: 135,585 shares; 2026Q1: 135,585 shares; 2026Q2: 135,585 shares; 2026Q3: 135,585 shares 135,585$12.4M0.53%0Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 34,693 shares; 2025Q1: 68,741 shares; 2025Q2: 155,557 shares; 2025Q3: 53,428 shares; 2025Q4: 63,673 shares; 2026Q1: 213,462 shares; 2026Q2: 220,462 shares; 2026Q3: 6,524,151 shares 6,524,151$12.3M0.53%+6,303,6892026-10-21, Form 4: bought 331,979 shares on 2026-10-21 Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 215,752 shares; 2025Q4: 215,752 shares; 2026Q1: 215,752 shares; 2026Q2: 216,752 shares; 2026Q3: 1,007,752 shares 1,007,752$12M0.52%+791,000Timeline
ABCLABCELLERA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 14,981 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 822,163 shares 822,163$12M0.51%newTimeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 8,000 shares; 2025Q2: 25,000 shares; 2025Q3: 90,688 shares; 2025Q4: 171,422 shares; 2026Q1: 213,473 shares; 2026Q2: 185,619 shares; 2026Q3: 185,619 shares 185,619$11.9M0.51%0Timeline
VOGXVOGENX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 522,175 shares 522,175$11.9M0.51%newTimeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,103,005 shares; 2025Q1: 5,122,105 shares; 2025Q2: 5,122,105 shares; 2025Q3: 5,247,603 shares; 2025Q4: 8,063,949 shares; 2026Q1: 6,606,572 shares; 2026Q2: 7,387,205 shares; 2026Q3: 5,708,755 shares 5,708,755$11.7M0.5%-1,678,450Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 130,532 shares; 2025Q1: 115,867 shares; 2025Q2: 115,867 shares; 2025Q3: 12,846 shares; 2025Q4: 4,285,000 shares; 2026Q1: 4,544,113 shares; 2026Q2: 7,417,479 shares; 2026Q3: 4,560,813 shares 4,560,813$11.4M0.49%-2,856,666Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 146,447 shares; 2026Q3: 397,719 shares 397,719$11.3M0.49%+251,272Timeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 276,348 shares 276,348$10.9M0.47%newTimeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 234,607 shares; 2025Q1: 398,152 shares; 2025Q2: 85,826 shares; 2025Q3: 128,865 shares; 2025Q4: 56,165 shares; 2026Q1: 93,665 shares; 2026Q2: 232,560 shares; 2026Q3: 433,807 shares 433,807$10.8M0.46%+201,247Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,471,587 shares; 2025Q2: 1,205,101 shares; 2025Q3: 866,202 shares; 2025Q4: 890,356 shares; 2026Q1: 1,000,604 shares; 2026Q2: 494,378 shares; 2026Q3: 366,968 shares 366,968$10.7M0.46%-127,410Timeline
HLXCHELIX ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000$10.5M0.45%0Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares; 2025Q3: 50,000 shares; 2025Q4: 80,000 shares; 2026Q1: 144,636 shares; 2026Q2: 652,750 shares; 2026Q3: 3,762,532 shares 3,762,532$10.4M0.45%+3,109,782Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 38,312 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,446,375 shares; 2026Q2: not reported; 2026Q3: 420,981 shares 420,981$10.3M0.44%newTimeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 680,626 shares; 2026Q3: 531,349 shares 531,349$10.1M0.43%-149,277Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 20,000 shares; 2025Q2: 40,000 shares; 2025Q3: 40,000 shares; 2025Q4: 90,999 shares; 2026Q1: 90,599 shares; 2026Q2: 143,199 shares; 2026Q3: 243,199 shares 243,199$9.87M0.42%+100,000Timeline
KZIAKAZIA THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 61,550 shares; 2026Q3: 967,740 shares 967,740$9.29M0.4%+906,190Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 48,125 shares; 2025Q1: 119,320 shares; 2025Q2: 119,320 shares; 2025Q3: 133,530 shares; 2025Q4: 1,432,475 shares; 2026Q1: 597,662 shares; 2026Q2: 822,649 shares; 2026Q3: 792,936 shares 792,936$9.09M0.39%-29,713Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,400 shares; 2025Q3: 978,894 shares; 2025Q4: 1,241,322 shares; 2026Q1: 1,582,987 shares; 2026Q2: 655,784 shares; 2026Q3: 655,784 shares 655,784$8.68M0.37%0Timeline
IRDOPUS GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 40,000 shares; 2026Q1: 1,849,004 shares; 2026Q2: 1,783,781 shares; 2026Q3: 1,783,781 shares 1,783,781$8.63M0.37%0Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,000 shares; 2025Q3: 102,969 shares; 2025Q4: 91,869 shares; 2026Q1: 91,869 shares; 2026Q2: 191,869 shares; 2026Q3: 496,965 shares 496,965$8.4M0.36%+305,096Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 12,800 shares; 2025Q2: 98,032 shares; 2025Q3: 213,064 shares; 2025Q4: 315,642 shares; 2026Q1: 259,137 shares; 2026Q2: 146,034 shares; 2026Q3: 146,034 shares 146,034$8.31M0.36%0Timeline
RACCRESEARCH ALLIANCE CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 650,000 shares; 2026Q3: 767,000 shares 767,000$8.31M0.36%+117,000Timeline
AMANAMANAT ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 750,000 shares; 2026Q3: 750,000 shares 750,000$7.99M0.34%0Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,625,980 shares 2,625,980$7.64M0.33%newTimeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,709,846 shares; 2026Q1: 2,174,398 shares; 2026Q2: 3,606,656 shares; 2026Q3: 2,066,330 shares 2,066,330$7.62M0.33%-1,540,326Timeline
JATTJATT II ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 417,724 shares; 2026Q3: 683,022 shares 683,022$7.6M0.33%+265,298Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 148,461 shares; 2025Q3: 133,818 shares; 2025Q4: 147,130 shares; 2026Q1: 160,338 shares; 2026Q2: 166,286 shares; 2026Q3: 169,593 shares 169,593$7.57M0.32%+3,307Timeline
RNAQURAINIER ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 742,500 shares 742,500$7.55M0.32%newTimeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 43,000 shares; 2026Q2: 291,957 shares; 2026Q3: 2,232,857 shares 2,232,857$7.44M0.32%+1,940,900Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 374,909 shares; 2026Q2: 26,497 shares; 2026Q3: 725,165 shares 725,165$7.39M0.32%+698,668Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 988,468 shares; 2025Q1: 1,360,291 shares; 2025Q2: 3,600,670 shares; 2025Q3: 1,988,288 shares; 2025Q4: 1,405,452 shares; 2026Q1: 1,464,535 shares; 2026Q2: 1,403,409 shares; 2026Q3: 1,410,409 shares 1,410,409$7.28M0.31%+7,000Timeline
CATXPERSPECTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 95,193 shares; 2026Q1: 749,335 shares; 2026Q2: 1,210,117 shares; 2026Q3: 2,617,870 shares 2,617,870$7.2M0.31%+1,407,753Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 18,000 shares; 2025Q1: 18,643 shares; 2025Q2: 18,643 shares; 2025Q3: 18,643 shares; 2025Q4: 23,643 shares; 2026Q1: 172,157 shares; 2026Q2: 338,373 shares; 2026Q3: 629,654 shares 629,654$6.88M0.3%+291,281Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 22,641 shares; 2025Q2: 32,341 shares; 2025Q3: 24,341 shares; 2025Q4: 34,277 shares; 2026Q1: 44,777 shares; 2026Q2: 501,687 shares; 2026Q3: 501,687 shares 501,687$6.7M0.29%0Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 28,604 shares; 2026Q3: 28,604 shares 28,604$6.52M0.28%0Timeline
DXYZDESTINY TECH100 INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 210,399 shares 210,399$6.49M0.28%newTimeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 282,996 shares 282,996$6.37M0.27%newTimeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,374 shares 500,374$6.26M0.27%newTimeline
RACDRESEARCH ALLIANCE CORP IVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 525,234 shares 525,234$6.22M0.27%newTimeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: 1,014,158 shares; 2026Q1: 2,434,941 shares; 2026Q2: 2,238,684 shares; 2026Q3: 2,238,684 shares 2,238,684$6.1M0.26%0Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 145,036 shares; 2025Q1: 47,036 shares; 2025Q2: 3,081,414 shares; 2025Q3: 4,045,414 shares; 2025Q4: 4,182,769 shares; 2026Q1: 3,410,190 shares; 2026Q2: 3,365,118 shares; 2026Q3: 2,204,454 shares 2,204,454$6M0.26%-1,160,664Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 281,000 shares 281,000$5.98M0.26%newTimeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 134,798 shares; 2025Q1: not reported; 2025Q2: 82,189 shares; 2025Q3: not reported; 2025Q4: 73,819 shares; 2026Q1: 2,585,126 shares; 2026Q2: 5,509,724 shares; 2026Q3: 5,509,724 shares 5,509,724$5.95M0.26%0Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 841,541 shares; 2025Q1: 263,425 shares; 2025Q2: 302,125 shares; 2025Q3: 78,238 shares; 2025Q4: 136,231 shares; 2026Q1: 154,686 shares; 2026Q2: 298,886 shares; 2026Q3: 227,294 shares 227,294$5.71M0.24%-71,592Timeline
OACCUOAKTREE ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: 516,482 shares; 2025Q2: 516,482 shares; 2025Q3: 516,482 shares; 2025Q4: 516,482 shares; 2026Q1: 516,482 shares; 2026Q2: 516,482 shares; 2026Q3: 516,482 shares 516,482$5.62M0.24%0Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 5,559,988 shares; 2025Q4: 5,608,078 shares; 2026Q1: 3,726,659 shares; 2026Q2: 3,758,569 shares; 2026Q3: 3,446,539 shares 3,446,539$5.6M0.24%-312,030Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 133,316 shares; 2025Q4: 235,155 shares; 2026Q1: 76,206 shares; 2026Q2: 324,672 shares; 2026Q3: 230,814 shares 230,814$5.58M0.24%-93,858Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,045 shares; 2025Q1: 4,500 shares; 2025Q2: 5,100 shares; 2025Q3: 18,000 shares; 2025Q4: 24,300 shares; 2026Q1: 11,000 shares; 2026Q2: 17,900 shares; 2026Q3: 24,400 shares 24,400$5.51M0.24%+6,500Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,523 shares; 2025Q4: 20,014 shares; 2026Q1: 20,014 shares; 2026Q2: 16,420 shares; 2026Q3: 16,420 shares 16,420$5.46M0.23%0Timeline
IFRXINFLARX NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 159,479 shares; 2025Q4: not reported; 2026Q1: 158,271 shares; 2026Q2: 3,000,000 shares; 2026Q3: 3,000,000 shares 3,000,000$5.4M0.23%0Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 57,978 shares; 2025Q1: 68,715 shares; 2025Q2: 68,815 shares; 2025Q3: 40,235 shares; 2025Q4: not reported; 2026Q1: 540,054 shares; 2026Q2: 540,054 shares; 2026Q3: 540,054 shares 540,054$5.35M0.23%0Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 169,505 shares; 2025Q1: 170,448 shares; 2025Q2: 145,109 shares; 2025Q3: 1,531,953 shares; 2025Q4: 1,393,161 shares; 2026Q1: 1,467,350 shares; 2026Q2: 1,565,950 shares; 2026Q3: 1,576,796 shares 1,576,796$5.33M0.23%+10,846Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 82,234 shares; 2025Q1: 168,765 shares; 2025Q2: 166,799 shares; 2025Q3: 77,961 shares; 2025Q4: 278,961 shares; 2026Q1: 276,661 shares; 2026Q2: 278,961 shares; 2026Q3: 384,890 shares 384,890$5.17M0.22%+105,929Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 31,035 shares; 2025Q1: 490,743 shares; 2025Q2: 915,130 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 23,900 shares; 2026Q2: 11,000 shares; 2026Q3: 1,492,000 shares 1,492,000$5.1M0.22%+1,481,000Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 77,593 shares; 2026Q1: 128,503 shares; 2026Q2: 1,341,394 shares; 2026Q3: 1,341,394 shares 1,341,394$5.04M0.22%0Timeline
BHAVUBHAV ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 495,000 shares; 2026Q2: 495,000 shares; 2026Q3: 495,000 shares 495,000$5.02M0.22%0Timeline
JTTTJATT III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 454,000 shares 454,000$5M0.21%newTimeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 56,120 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 90,593 shares; 2026Q2: 90,593 shares; 2026Q3: 526,996 shares 526,996$4.99M0.21%+436,403Timeline
PRMEPRIME MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,973,282 shares; 2026Q2: 1,997,552 shares; 2026Q3: 1,598,042 shares 1,598,042$4.88M0.21%-399,510Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,000 shares; 2025Q4: 15,000 shares; 2026Q1: 405,197 shares; 2026Q2: 374,617 shares; 2026Q3: 70,029 shares 70,029$4.86M0.21%-304,588Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 62,500 shares 62,500$4.77M0.2%newTimeline
MGNXMACROGENICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,000 shares; 2026Q2: 129,822 shares; 2026Q3: 1,234,595 shares 1,234,595$4.77M0.2%+1,104,773Timeline
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,968,216 shares; 2026Q3: 1,893,439 shares 1,893,439$4.75M0.2%-74,777Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 94,294 shares; 2025Q1: 146,183 shares; 2025Q2: 916,183 shares; 2025Q3: 891,183 shares; 2025Q4: 891,183 shares; 2026Q1: 2,156,334 shares; 2026Q2: 2,111,334 shares; 2026Q3: 2,114,334 shares 2,114,334$4.69M0.2%+3,000Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,600 shares; 2026Q1: 30,932 shares; 2026Q2: 25,932 shares; 2026Q3: 21,132 shares 21,132$4.68M0.2%-4,800Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 368,330 shares; 2025Q1: 380,330 shares; 2025Q2: 1,723,526 shares; 2025Q3: not reported; 2025Q4: 1,108,000 shares; 2026Q1: 1,050,000 shares; 2026Q2: 2,883,583 shares; 2026Q3: 2,514,840 shares 2,514,840$4.65M0.2%-368,743Timeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 35,050 shares; 2025Q1: 41,050 shares; 2025Q2: 39,400 shares; 2025Q3: 44,400 shares; 2025Q4: 72,400 shares; 2026Q1: 77,400 shares; 2026Q2: 252,400 shares; 2026Q3: 162,400 shares 162,400$4.63M0.2%-90,000Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,900 shares; 2025Q1: 56,300 shares; 2025Q2: 55,200 shares; 2025Q3: 49,800 shares; 2025Q4: 58,200 shares; 2026Q1: 70,300 shares; 2026Q2: 69,800 shares; 2026Q3: 69,200 shares 69,200$4.53M0.19%-600Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 101,008 shares; 2025Q1: 101,008 shares; 2025Q2: 101,008 shares; 2025Q3: 101,008 shares; 2025Q4: 101,008 shares; 2026Q1: 231,008 shares; 2026Q2: 201,008 shares; 2026Q3: 2,700,349 shares 2,700,349$4.51M0.19%+2,499,341Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 9,000 shares; 2025Q4: not reported; 2026Q1: 13,400 shares; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$4.51M0.19%newTimeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 67,077 shares; 2026Q1: 524,441 shares; 2026Q2: 404,014 shares; 2026Q3: 267,067 shares 267,067$4.3M0.18%-136,947Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,974 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 11,701 shares; 2026Q2: 11,701 shares; 2026Q3: 11,701 shares 11,701$4.28M0.18%0Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 215,750 shares; 2025Q1: 301,134 shares; 2025Q2: 523,216 shares; 2025Q3: 248,917 shares; 2025Q4: 258,139 shares; 2026Q1: 185,699 shares; 2026Q2: 118,664 shares; 2026Q3: 59,332 shares 59,332$4.21M0.18%-59,332Timeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 13,173 shares; 2025Q1: 43,173 shares; 2025Q2: 43,173 shares; 2025Q3: 47,800 shares; 2025Q4: 47,800 shares; 2026Q1: 47,800 shares; 2026Q2: 53,800 shares; 2026Q3: 508,199 shares 508,199$4.11M0.18%+454,399Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 358,333 shares; 2026Q3: 212,500 shares 212,500$3.84M0.16%-145,833Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 700 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,020 shares; 2026Q1: 1,830 shares; 2026Q2: 6,030 shares; 2026Q3: 9,230 shares 9,230$3.75M0.16%+3,200Timeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,100 shares; 2026Q1: 20,100 shares; 2026Q2: 70,100 shares; 2026Q3: 50,100 shares 50,100$3.75M0.16%-20,000Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 35,000 shares; 2025Q1: 10,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,000 shares; 2026Q1: 105,000 shares; 2026Q2: 133,000 shares; 2026Q3: 447,105 shares 447,105$3.72M0.16%+314,105Timeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 722,419 shares 722,419$3.62M0.16%new2026-11-11, Form 4: bought 12,333 shares on 2026-11-11 Timeline
RNTXREIN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,500,000 shares; 2026Q3: 4,500,000 shares 4,500,000$3.62M0.16%0Timeline
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 149,385 shares; 2025Q1: 149,385 shares; 2025Q2: 149,385 shares; 2025Q3: 224,385 shares; 2025Q4: 224,385 shares; 2026Q1: 224,385 shares; 2026Q2: 224,385 shares; 2026Q3: 224,385 shares 224,385$3.58M0.15%0Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 20,352 shares; 2025Q2: 20,352 shares; 2025Q3: 36,842 shares; 2025Q4: 36,842 shares; 2026Q1: 1,607,638 shares; 2026Q2: 2,591,085 shares; 2026Q3: 1,440,874 shares 1,440,874$3.49M0.15%-1,150,211Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 606,000 shares; 2026Q1: 50,273 shares; 2026Q2: 18,275 shares; 2026Q3: 231,328 shares 231,328$3.38M0.14%+213,053Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 34,124 shares; 2025Q3: 34,124 shares; 2025Q4: 85,528 shares; 2026Q1: 105,528 shares; 2026Q2: 105,528 shares; 2026Q3: 105,528 shares 105,528$3.35M0.14%0Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,077,251 shares; 2025Q1: 2,801,184 shares; 2025Q2: 997,547 shares; 2025Q3: 652,154 shares; 2025Q4: 562,065 shares; 2026Q1: 630,403 shares; 2026Q2: 1,759,295 shares; 2026Q3: 785,059 shares 785,059$3.27M0.14%-974,236Timeline
CCXICHURCHILL CAP CORP XIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares; 2026Q3: 273,467 shares 273,467$3.18M0.14%+223,467Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 4,900 shares; 2025Q2: 4,900 shares; 2025Q3: 4,900 shares; 2025Q4: 12,900 shares; 2026Q1: 18,200 shares; 2026Q2: 49,000 shares; 2026Q3: 51,200 shares 51,200$3.07M0.13%+2,200Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 112,359 shares; 2025Q3: 114,359 shares; 2025Q4: 118,623 shares; 2026Q1: 118,623 shares; 2026Q2: 118,623 shares; 2026Q3: 118,623 shares 118,623$2.88M0.12%0Timeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 393,701 shares; 2026Q1: 727,481 shares; 2026Q2: 777,100 shares; 2026Q3: 777,100 shares 777,100$2.77M0.12%0Timeline
KROSKEROS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 23,246 shares; 2025Q1: 1,486,461 shares; 2025Q2: 5,389,264 shares; 2025Q3: 5,389,264 shares; 2025Q4: 18,851 shares; 2026Q1: 97,318 shares; 2026Q2: 246,818 shares; 2026Q3: 239,194 shares 239,194$2.73M0.12%-7,624Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,104,986 shares; 2026Q3: 1,329,986 shares 1,329,986$2.66M0.11%-775,000Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 122,690 shares; 2025Q1: 122,690 shares; 2025Q2: 122,690 shares; 2025Q3: 35,223 shares; 2025Q4: 1,136,799 shares; 2026Q1: 940,512 shares; 2026Q2: 940,512 shares; 2026Q3: 850,512 shares 850,512$2.59M0.11%-90,000Timeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 58,000 shares; 2026Q1: 58,600 shares; 2026Q2: 67,717 shares; 2026Q3: 51,646 shares 51,646$2.51M0.11%-16,071Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 59,230 shares; 2025Q4: 369,569 shares; 2026Q1: 1,361,536 shares; 2026Q2: 600,999 shares; 2026Q3: 560,999 shares 560,999$2.42M0.1%-40,000Timeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,366 shares; 2025Q3: 10,366 shares; 2025Q4: 10,366 shares; 2026Q1: 10,366 shares; 2026Q2: 10,366 shares; 2026Q3: 1,886,346 shares 1,886,346$2.28M0.1%+1,875,980Timeline
RNAATRIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 57,688 shares; 2026Q2: 57,688 shares; 2026Q3: 267,586 shares 267,586$2.22M0.1%+209,898Timeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 222,555 shares; 2026Q2: 222,555 shares; 2026Q3: 256,687 shares 256,687$2.18M0.09%+34,132Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 25,000 shares 25,000$2.16M0.09%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,004,845 shares; 2026Q1: 2,264,845 shares; 2026Q2: 1,726,662 shares; 2026Q3: 1,541,747 shares 1,541,747$2.08M0.09%-184,915Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 130,000 shares; 2025Q3: not reported; 2025Q4: 30,866 shares; 2026Q1: 451,918 shares; 2026Q2: 451,918 shares; 2026Q3: 551,918 shares 551,918$2.08M0.09%+100,000Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 123,037 shares; 2025Q1: 971,100 shares; 2025Q2: 1,937,123 shares; 2025Q3: 1,880,073 shares; 2025Q4: 135,560 shares; 2026Q1: 135,560 shares; 2026Q2: not reported; 2026Q3: 276,000 shares 276,000$1.96M0.08%newTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 41,346 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 140,021 shares; 2026Q1: 50,000 shares; 2026Q2: 76,761 shares; 2026Q3: 77,000 shares 77,000$1.92M0.08%+239Timeline
HOWLWEREWOLF THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,023,331 shares 2,023,331$1.87M0.08%newTimeline
INOINOVIO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,485,008 shares; 2026Q1: 1,470,108 shares; 2026Q2: 2,143,910 shares; 2026Q3: 1,444,165 shares 1,444,165$1.76M0.08%-699,745Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,000 shares; 2025Q1: 16,600 shares; 2025Q2: 16,900 shares; 2025Q3: not reported; 2025Q4: 1,821,812 shares; 2026Q1: 974,421 shares; 2026Q2: 647,812 shares; 2026Q3: 652,812 shares 652,812$1.65M0.07%+5,000Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,500 shares; 2026Q1: 33,900 shares; 2026Q2: 30,300 shares; 2026Q3: 32,300 shares 32,300$1.61M0.07%+2,000Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,000 shares; 2026Q1: 10,000 shares; 2026Q2: 7,500 shares; 2026Q3: 36,000 shares 36,000$1.57M0.07%+28,500Timeline
CCIIUCOHEN CIRCLE ACQUISIT CORP IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 150,000 shares; 2025Q4: 150,000 shares; 2026Q1: 150,000 shares; 2026Q2: 150,000 shares; 2026Q3: 150,000 shares 150,000$1.57M0.07%0Timeline
WVEWAVE LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 409,084 shares 409,084$1.51M0.06%newTimeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,370,987 shares; 2025Q4: 3,899,397 shares; 2026Q1: 3,822,427 shares; 2026Q2: 3,807,427 shares; 2026Q3: 1,666,322 shares 1,666,322$1.45M0.06%-2,141,105Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 750,000 shares; 2026Q2: 750,000 shares; 2026Q3: 750,000 shares 750,000$1.41M0.06%0Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,000 shares; 2026Q3: 12,275 shares 12,275$1.4M0.06%+9,275Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 43,574 shares 43,574$1.39M0.06%newTimeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,000 shares; 2026Q2: not reported; 2026Q3: 70,000 shares 70,000$1.39M0.06%newTimeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,200 shares; 2025Q4: 286,781 shares; 2026Q1: 331,781 shares; 2026Q2: 421,787 shares; 2026Q3: 195,469 shares 195,469$1.33M0.06%-226,318Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 465,875 shares; 2026Q1: 87,901 shares; 2026Q2: 117,101 shares; 2026Q3: 112,100 shares 112,100$1.29M0.06%-5,001Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 27,925 shares; 2025Q2: 29,625 shares; 2025Q3: 30,633 shares; 2025Q4: 30,633 shares; 2026Q1: not reported; 2026Q2: 7,800 shares; 2026Q3: 43,800 shares 43,800$1.22M0.05%+36,000Timeline
SUPNSUPERNUS PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,418 shares; 2025Q4: 29,742 shares; 2026Q1: 29,642 shares; 2026Q2: 27,842 shares; 2026Q3: 27,842 shares 27,842$1.2M0.05%0Timeline
AEXAAMERICAN EXCEPTIONALISM ACQUQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 357,539 shares; 2026Q1: 357,539 shares; 2026Q2: 205,408 shares; 2026Q3: 105,408 shares 105,408$1.17M0.05%-100,000Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 211,400 shares; 2025Q1: 241,800 shares; 2025Q2: 275,800 shares; 2025Q3: 575,800 shares; 2025Q4: 475,800 shares; 2026Q1: 432,500 shares; 2026Q2: 435,500 shares; 2026Q3: 442,500 shares 442,500$1.16M0.05%+7,000Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 58,708 shares; 2025Q1: 62,603 shares; 2025Q2: 73,505 shares; 2025Q3: 56,007 shares; 2025Q4: 30,007 shares; 2026Q1: 13,001 shares; 2026Q2: 14,501 shares; 2026Q3: 49,501 shares 49,501$1.15M0.05%+35,000Timeline
CUECUE BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 55,193 shares; 2026Q3: 43,935 shares 43,935$1.14M0.05%-11,258Timeline
STIPISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,000 shares; 2026Q3: 11,000 shares 11,000$1.1M0.05%+7,000Timeline
NVONOVO-NORDISK A SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 33,000 shares; 2026Q2: 27,000 shares; 2026Q3: 28,000 shares 28,000$1.06M0.05%+1,000Timeline
GRCEGRACE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 773,635 shares; 2025Q1: 343,512 shares; 2025Q2: 176,627 shares; 2025Q3: 350,450 shares; 2025Q4: 641,988 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 476,190 shares 476,190$1.02M0.04%newTimeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,600 shares; 2026Q3: 10,300 shares 10,300$1.01M0.04%-300Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 23,700 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,500 shares 10,500$995K0.04%newTimeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 71,910 shares; 2026Q3: 27,898 shares 27,898$989K0.04%-44,012Timeline
PMNPROMIS NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 95,350 shares; 2026Q2: 92,850 shares; 2026Q3: 92,850 shares 92,850$977K0.04%0Timeline
SIBNSI BONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 12,580 shares; 2026Q2: 45,000 shares; 2026Q3: 50,000 shares 50,000$940K0.04%+5,000Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,505,300 shares; 2026Q1: 1,507,800 shares; 2026Q2: 1,555,500 shares; 2026Q3: 1,555,500 shares 1,555,500$939K0.04%0Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 4,250 shares; 2025Q2: 2,500 shares; 2025Q3: not reported; 2025Q4: 2,147 shares; 2026Q1: 2,147 shares; 2026Q2: 2,147 shares; 2026Q3: 2,147 shares 2,147$887K0.04%0Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 533,660 shares; 2026Q3: 625,433 shares 625,433$869K0.04%+91,773Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 35,319 shares; 2025Q1: 35,619 shares; 2025Q2: 15,000 shares; 2025Q3: 15,200 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 17,500 shares; 2026Q3: 27,500 shares 27,500$860K0.04%+10,000Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 14,733 shares; 2026Q1: 16,033 shares; 2026Q2: 18,322 shares; 2026Q3: 26,322 shares 26,322$850K0.04%+8,000Timeline
SGOVISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,000 shares 8,000$805K0.03%newTimeline
AREALEXANDRIA REAL ESTATE EQ INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 16,300 shares; 2026Q1: 19,500 shares; 2026Q2: 19,500 shares; 2026Q3: 16,900 shares 16,900$802K0.03%-2,600Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,859 shares; 2026Q1: 55,859 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$800K0.03%0Timeline
CORZCORE SCIENTIFIC INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$799K0.03%newTimeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 28,221 shares; 2025Q1: not reported; 2025Q2: 204,497 shares; 2025Q3: 214,497 shares; 2025Q4: 355,410 shares; 2026Q1: 374,497 shares; 2026Q2: 404,497 shares; 2026Q3: 404,497 shares 404,497$773K0.03%0Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 742,400 shares; 2026Q2: 700,000 shares; 2026Q3: 700,000 shares 700,000$770K0.03%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000$768K0.03%0Timeline
TECHBIO-TECHNE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,500 shares 10,500$761K0.03%newTimeline
VCREVICORE PHARMA HLDG ABQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 79,900 shares 79,900$760K0.03%newTimeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 237,605 shares; 2025Q3: 235,689 shares; 2025Q4: 185,689 shares; 2026Q1: 52,745 shares; 2026Q2: 272,745 shares; 2026Q3: 237,735 shares 237,735$760K0.03%-35,010Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$733K0.03%newTimeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 49,963 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,000 shares; 2026Q2: 12,500 shares; 2026Q3: 12,500 shares 12,500$730K0.03%0Timeline
TXMDTHERAPEUTICSMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 270,160 shares; 2025Q1: 270,160 shares; 2025Q2: 209,210 shares; 2025Q3: 209,210 shares; 2025Q4: 209,210 shares; 2026Q1: 209,210 shares; 2026Q2: 342,447 shares; 2026Q3: 342,447 shares 342,447$695K0.03%0Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 6,666 shares; 2026Q1: 6,351 shares; 2026Q2: 4,648 shares; 2026Q3: 4,648 shares 4,648$693K0.03%0Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 166,406 shares; 2025Q1: 41,412 shares; 2025Q2: 56,540 shares; 2025Q3: 75,187 shares; 2025Q4: 28,728 shares; 2026Q1: 26,913 shares; 2026Q2: 26,913 shares; 2026Q3: 9,258 shares 9,258$691K0.03%-17,655Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 184,062 shares; 2026Q1: 184,062 shares; 2026Q2: 104,035 shares; 2026Q3: 82,350 shares 82,350$680K0.03%-21,685Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 337,676 shares; 2025Q1: 266,176 shares; 2025Q2: 441,176 shares; 2025Q3: 456,176 shares; 2025Q4: 336,176 shares; 2026Q1: 200,000 shares; 2026Q2: 505,817 shares; 2026Q3: 505,817 shares 505,817$622K0.03%0Timeline
ARTVARTIVA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 118,624 shares; 2026Q3: 86,805 shares 86,805$618K0.03%-31,819Timeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,359,208 shares; 2025Q1: 1,116,047 shares; 2025Q2: 989,297 shares; 2025Q3: 815,975 shares; 2025Q4: 38,679 shares; 2026Q1: 58,679 shares; 2026Q2: 48,679 shares; 2026Q3: 148,679 shares 148,679$616K0.03%+100,000Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 71,100 shares; 2026Q2: 75,800 shares; 2026Q3: 72,800 shares 72,800$586K0.03%-3,000Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 30,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 40,800 shares 40,800$584K0.03%newTimeline
PYPDPOLYPID LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 80,080 shares; 2025Q1: 80,080 shares; 2025Q2: 103,950 shares; 2025Q3: not reported; 2025Q4: 103,950 shares; 2026Q1: 103,950 shares; 2026Q2: 103,950 shares; 2026Q3: 103,950 shares 103,950$548K0.02%0Timeline
RNACCARTESIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 98,877 shares; 2026Q3: 73,877 shares 73,877$533K0.02%-25,000Timeline
GTERUGLOBA TERRA ACQUISITION CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 50,000 shares; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares; 2026Q3: 50,000 shares 50,000$523K0.02%0Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 26,000 shares; 2026Q3: 25,000 shares 25,000$504K0.02%-1,000Timeline
USFRWISDOMTREE TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000$504K0.02%0Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,947 shares; 2025Q4: 19,747 shares; 2026Q1: 19,947 shares; 2026Q2: 20,447 shares; 2026Q3: 21,447 shares 21,447$504K0.02%+1,000Timeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 118,209 shares 118,209$461K0.02%newTimeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,490 shares; 2025Q2: 1,054 shares; 2025Q3: 4,895 shares; 2025Q4: 895 shares; 2026Q1: 895 shares; 2026Q2: 895 shares; 2026Q3: 895 shares 895$451K0.02%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 313,354 shares; 2025Q2: 128,767 shares; 2025Q3: 82,591 shares; 2025Q4: 58,091 shares; 2026Q1: 57,591 shares; 2026Q2: 57,591 shares; 2026Q3: 57,591 shares 57,591$445K0.02%0Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,788 shares; 2025Q3: 61,291 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 60,000 shares 60,000$443K0.02%newTimeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 415,606 shares; 2025Q1: not reported; 2025Q2: 54,819 shares; 2025Q3: 27,000 shares; 2025Q4: 405,531 shares; 2026Q1: 469,878 shares; 2026Q2: 375,531 shares; 2026Q3: 375,531 shares 375,531$443K0.02%0Timeline
KARDKARDIGAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 30,000 shares 30,000$442K0.02%newTimeline
KPRXKIORA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,221 shares; 2025Q1: 194,665 shares; 2025Q2: 167,111 shares; 2025Q3: 167,941 shares; 2025Q4: 167,941 shares; 2026Q1: 167,941 shares; 2026Q2: 167,941 shares; 2026Q3: 167,941 shares 167,941$430K0.02%0Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 25,000 shares; 2025Q2: 34,300 shares; 2025Q3: 55,000 shares; 2025Q4: 40,000 shares; 2026Q1: 40,000 shares; 2026Q2: 40,000 shares; 2026Q3: 40,000 shares 40,000$428K0.02%0Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 35,000 shares; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$414K0.02%newTimeline
IHIISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,900 shares; 2026Q3: 7,700 shares 7,700$394K0.02%+2,800Timeline
BABAALIBABA GROUP HLDG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,578 shares; 2025Q4: 3,578 shares; 2026Q1: 3,578 shares; 2026Q2: 3,578 shares; 2026Q3: 3,578 shares 3,578$385K0.02%0Timeline
IBRXIMMUNITYBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 40,000 shares 40,000$378K0.02%newTimeline
CNSPCNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 70,000 shares; 2026Q3: 70,000 shares 70,000$371K0.02%0Timeline
NAUTNAUTILUS BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 251,926 shares 251,926$358K0.02%newTimeline
BMEABIOMEA FUSION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 43,420 shares; 2026Q1: 43,420 shares; 2026Q2: 43,420 shares; 2026Q3: 268,420 shares 268,420$357K0.02%+225,000Timeline
TRAWTRAWS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 154,431 shares; 2026Q1: 154,098 shares; 2026Q2: 597,729 shares; 2026Q3: 597,729 shares 597,729$355K0.02%0Timeline
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 49,387 shares; 2026Q3: 69,387 shares 69,387$343K0.01%+20,000Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,200 shares; 2026Q2: 3,900 shares; 2026Q3: 3,900 shares 3,900$333K0.01%0Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 17,424 shares; 2025Q1: 5,424 shares; 2025Q2: 34,314 shares; 2025Q3: 151,495 shares; 2025Q4: not reported; 2026Q1: 457,137 shares; 2026Q2: 27,000 shares; 2026Q3: 27,000 shares 27,000$316K0.01%0Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 55,400 shares; 2025Q1: 42,800 shares; 2025Q2: 63,424 shares; 2025Q3: 42,900 shares; 2025Q4: 42,900 shares; 2026Q1: 42,900 shares; 2026Q2: 42,900 shares; 2026Q3: 42,900 shares 42,900$313K0.01%0Timeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 13,861 shares; 2026Q2: 58,808 shares; 2026Q3: 58,808 shares 58,808$313K0.01%0Timeline
WWWW INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 52,450 shares; 2025Q4: 57,100 shares; 2026Q1: 57,700 shares; 2026Q2: 21,300 shares; 2026Q3: 20,100 shares 20,100$311K0.01%-1,200Timeline
ALTALTIMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 102,823 shares; 2026Q3: 102,823 shares 102,823$294K0.01%0Timeline
RXSTRXSIGHT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,803 shares; 2026Q1: 43,250 shares; 2026Q2: 50,000 shares; 2026Q3: 60,000 shares 60,000$294K0.01%+10,000Timeline
PCAPUPROCAP ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,680 shares; 2025Q3: 26,940 shares; 2025Q4: 26,940 shares; 2026Q1: 26,940 shares; 2026Q2: 26,940 shares; 2026Q3: 26,940 shares 26,940$282K0.01%0Timeline
DERMJOURNEY MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 39,517 shares; 2026Q3: 39,517 shares 39,517$270K0.01%0Timeline
JDJD.COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000$266K0.01%0Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,875 shares; 2025Q3: 13,705 shares; 2025Q4: 13,705 shares; 2026Q1: 13,705 shares; 2026Q2: 13,705 shares; 2026Q3: 13,705 shares 13,705$255K0.01%0Timeline
STIMNEURONETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$234K0.01%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,000 shares; 2025Q1: 15,000 shares; 2025Q2: 35,000 shares; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares; 2026Q2: 41,000 shares; 2026Q3: 56,000 shares 56,000$231K0.01%+15,000Timeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 351,094 shares; 2025Q1: 351,094 shares; 2025Q2: 351,094 shares; 2025Q3: 351,094 shares; 2025Q4: 351,094 shares; 2026Q1: 351,094 shares; 2026Q2: 750,969 shares; 2026Q3: 750,969 shares 750,969$226K0.01%0Timeline
COYACOYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,900 shares; 2026Q2: 40,900 shares; 2026Q3: 40,900 shares 40,900$205K0.01%0Timeline
CEPSCANTOR EQUITY PARTNERS VI INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000$204K0.01%0Timeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 60,000 shares 60,000$173K0.01%-40,000Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 68,608 shares; 2025Q1: 26,108 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,600 shares; 2026Q1: 33,100 shares; 2026Q2: 210,000 shares; 2026Q3: 246,000 shares 246,000$147K0.01%+36,000Timeline
OGNORGANON & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 40,200 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 35,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000$137K0.01%0Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 25,000 shares; 2025Q3: 50,000 shares; 2025Q4: 139,000 shares; 2026Q1: 139,000 shares; 2026Q2: 122,132 shares; 2026Q3: 119,500 shares 119,500$124K0.01%-2,632Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 373,682 shares; 2025Q4: 613,986 shares; 2026Q1: 132,426 shares; 2026Q2: not reported; 2026Q3: 22,000 shares 22,000$116K<0.01%newTimeline
NEUPNEUPHORIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares; 2026Q2: 30,000 shares; 2026Q3: 30,000 shares 30,000$107K<0.01%0Timeline
CAESCANTOR EQUITY PARTNERS VII IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000$101K<0.01%0Timeline
KYNBKYNTRA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,469 shares; 2026Q1: 10,469 shares; 2026Q2: not reported; 2026Q3: 14,341 shares 14,341$95.4K<0.01%newTimeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 126,792 shares; 2025Q1: 75,545 shares; 2025Q2: 79,945 shares; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares; 2026Q2: 35,000 shares; 2026Q3: 35,000 shares 35,000$93.8K<0.01%0Timeline
VERUVERU INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares; 2026Q2: 35,000 shares; 2026Q3: 35,000 shares 35,000$93.1K<0.01%0Timeline
LABDDIREXION SHARES ETF TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 13,211 shares 13,211$92.9K<0.01%newTimeline
LITSLITE STRATEGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 292,397 shares; 2025Q4: 67,292 shares; 2026Q1: 67,292 shares; 2026Q2: 67,292 shares; 2026Q3: 67,292 shares 67,292$88.8K<0.01%0Timeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,100 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$86.6K<0.01%0Timeline
CABACABALETTA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares; 2026Q3: 40,000 shares 40,000$76.8K<0.01%-10,000Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 501,228 shares; 2025Q4: 226,248 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 17,183 shares 17,183$70.5K<0.01%newTimeline
CLNNCLENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 15,000 shares; 2026Q3: 15,000 shares 15,000$61.2K<0.01%0Timeline
ABUSARBUTUS BIOPHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,554,802 shares; 2025Q1: 1,879,114 shares; 2025Q2: 2,825,773 shares; 2025Q3: 2,903,226 shares; 2025Q4: 5,415,109 shares; 2026Q1: 3,133,175 shares; 2026Q2: 1,268,147 shares; 2026Q3: 10,522 shares 10,522$50.3K<0.01%-1,257,625Timeline
LGVNLONGEVERON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,840 shares 10,840$29.2K<0.01%newTimeline
ASPCRA SPAC III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 215,000 shares; 2025Q2: 215,000 shares; 2025Q3: 215,000 shares; 2025Q4: 215,000 shares; 2026Q1: 215,000 shares; 2026Q2: 215,000 shares; 2026Q3: 215,000 shares 215,000$21.4K<0.01%0Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 20,394 shares; 2025Q1: 20,394 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000$16.6K<0.01%0Timeline
BSAARBEST SPAC I ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$7.25K<0.01%0Timeline
DGACUDISCIPLINED GROWTH ACQUIS COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000$00%0Value filed as zero, left out of ratios.Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
PRAXPRAXIS PRECISION MEDICINES I COM NEWcall30,000$8.74Mnew
ABVXABIVAX SA SPONSORED ADScall70,000$6.93M+25,600
IOVAIOVANCE BIOTHERAPEUTICS INC COMput50,000$741Knew
RAREULTRAGENYX PHARMACEUTICAL IN COMcall20,000$301K0

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
VIKING THERAPEUTICS INCVIKING THERAPEUTICS INC NOTE 2.000%10/1principal100,000$9.95Mnew
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC Convertibleprincipal45,000$4.65M0
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC NOTE 1.750% 3/0principal30,000$4.53M0
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC NOTE 2.500% 3/1principal20,000$3.11M0
ARROWHEAD PHARMACEUTICALS INARROWHEAD PHARMACEUTICALS IN Convertibleprincipal10,000$1.03M0
CYTOKINETICS INCCYTOKINETICS INC NOTE 1.750%10/0principal5,000$621Knew

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CRNXCRINETICS PHARMACEUTICALS IN1,222,080$45.7Mshares
IWMISHARES TR62,500$18.8Mput
SPYSTATE STR SPDR S&P 500 ETF T25,000$18.7Mput
XBISPDR SERIES TRUST67,400$10.7Mput
TEVATEVA PHARMACEUTICAL INDS LTD277,848$9.41Mshares
FTHFAETH THERAPEUTICS INC361,010$9.03Mshares
FRNMPERCEPTIVE CAP SOLUTIONS COR674,695$7.34Mshares
DMRADAMORA THERAPEUTICS INC280,000$7.28Mshares
BHFBRIGHTHOUSE FINL INC95,523$6.05Mshares
ATAIATAIBECKLEY INC913,242$4.81Mshares
PRLDPRELUDE THERAPEUTICS INC900,900$4.8Mshares
APGEAPOGEE THERAPEUTICS INC31,000$4.11Mshares
SGMTSAGIMET BIOSCIENCES INC437,500$3.38Mshares
OABIOMNIAB INC947,412$2.33Mshares
ORKAORUKA THERAPEUTICS INC20,840$1.98Mshares
VYNEVYNE THERAPEUTICS INC2,950,000$1.92Mshares
MCKMCKESSON CORP2,500$1.89Mshares
AVTRAVANTOR INC130,000$1.29Mshares
INMINMED PHARMACEUTICALS INC800,000$1.24Mshares
CYCNCYCLERION THERAPEUTICS INC298,757$1.01Mshares
EAELECTRONIC ARTS INC4,936$1.01Mshares
TRAVERE THERAPEUTICS INCTRAVERE THERAPEUTICS INC10,000$1Mprincipal
ACADACADIA PHARMACEUTICALS INC38,955$986Kshares
DYNDYNE THERAPEUTICS INC42,821$951Kshares
KVACFKEEN VISION ACQUISITION CORP75,000$930Kcall
WVEWAVE LIFE SCIENCES LTD160,000$930Kshares
NUVLNUVALENT INC6,942$857Kshares
ADGMADAGIO MED HLDGS INC1,205,447$785Kshares
AMLXAMYLYX PHARMACEUTICALS INC40,100$720Kput
FWRDFORWARD AIR CORP48,241$652Kshares
SYKSTRYKER CORPORATION2,000$630Kshares
NVONOVO-NORDISK A S13,000$623Kcall
IOVAIOVANCE BIOTHERAPEUTICS INC146,090$608Kshares
CRBPCORBUS PHARMACEUTICALS HLDGS60,000$563Kcall
HELPCYBIN INC81,278$537Kshares
BNTCBENITEC BIOPHARMA INC40,000$535Kshares
KIDSORTHOPEDIATRICS CORP25,000$478Kshares
MRKMERCK & CO INC3,140$403Kshares
ANABANAPTYSBIO INC3,698$250Kshares
BCYCBICYCLE THERAPEUTICS PLC50,638$215Kshares
PSNLPERSONALIS INC15,000$201Kshares
QCLSQ/C TECHNOLOGIES INC50,000$195Kshares
CMMBCHEMOMAB THERAPEUTICS LTD80,000$130Kshares
STISOLIDION TECHNOLOGY INC13,500$125Kcall
TRDAENTRADA THERAPEUTICS INC15,500$114Kshares
VTGNVISTAGEN THERAPEUTICS INC351,141$79.4Kshares
LGVNLONGEVERON INC108,406$76.2Kshares
JSPRJASPER THERAPEUTICS INC140,000$58.9Kshares
GOSSGOSSAMER BIO INC212,531$35Kshares
ATYRATYR PHARMA INC50,685$30.2Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001940272-26-000033 base2026-11-16
13F-HR/A 0001940272-26-000034 addednew holdings2026-11-16